Active, not recruitingPhase 2NCT06846398
A Phase 2 in Adult Subjects With Hereditary Angioedema
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Principal Investigator
- Markus Magerl, DoctorCharite-Universitaetsmedizin Berlin - Klinik fuer Dermatologie Venerologie und Allergologie
- Intervention
- BW-20805(drug)
- Enrollment
- 25 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2025 – 2026
Study locations (18)
- Institute for Asthma and Allergy - Wheaton, Silver Spring, Maryland, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University Medicine Center, Durham, North Carolina, United States
- Penn State Milton S. Hershey MC - Penn State, Hershey, Pennsylvania, United States
- Inova Clinical Trials and Research Center, Falls Church, Virginia, United States
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
- The First Hospital of Lanzhou University, Lanzhou, Gansu, China
- Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
- Yantai Yuhuangding Hospital, Yantai, Shandong, China
- West China Hospital, Sichuan University, Chengdu, Sichaun, China
- First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Universitätsmedizin der Johannes Gutenberg, Mainz, Rhineland-Palatinate, Germany
- Charité - Universitätsmedizin Berlin, Berlin, State of Berlin, Germany
- Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco, Catania, Catania, Italy
- Azienda Ospedaliero-Universitaria Careggi, Florence, Florence, Italy
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06846398 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.